Article in Clinical and translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
8 authors.
Chenhao XuDepartment of Hepatobiliary and Pancreatic Surgery, Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Renyi SuDepartment of Hepatobiliary and Pancreatic Surgery, Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Yisu SongDepartment of Hepatobiliary and Pancreatic Surgery, Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Wenzhi ShuDepartment of Hepatobiliary and Pancreatic Surgery, Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Mengfan YangDepartment of Organ Transplantation, Qilu Hospital of Shandong University, Jinan, China.
Zhe YangDepartment of Hepatobiliary and Pancreatic Surgery, Department of Liver Transplantation, Shulan (Hangzhou) Hospital, Zhejiang Shuren University School of Medicine, Hangzhou, China.
Xiao XuInstitute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, China.
Xuyong WeiDepartment of Hepatobiliary and Pancreatic Surgery, Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, China.ORCID https://orcid.org/0000-0001-8755-5268
Funding
Construction Fund of Key Medical Disciplines of Hangzhou OO20190001Hainan Province Science and Technology Special Fund ZDYF2025LCLH012Hangzhou New Medical Talent ProjectHangzhou West Lake Pearl ProjectKey Program National Natural Science Foundation of China 81930016Key Research and Development Project of Zhejiang Province 2023C03046Key Research and Development Project of Zhejiang Province 2024C03149National Key R&D Program of China 2021YFA1100502National Key R&D Program of China 2023YFC2306800National Key Research and Development Program of China 2021YFA1100502National Key Research and Development Program of China 2021YFA1100504National Key Research and Development Program of China 2023YFC2306800National Natural Science Foundation of China 82470690National Natural Science Foundation of China 92159202Zhejiang Provincial Natural Science Foundation of China LQ22H160052
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Integrating spatial transcriptomics and single-cell RNA-seq dissects immune microenvironment in fatty liver regeneration. · full record | OpenQuestion